Spectrum of cardiac lesions associated with Isolated Cleft Mitral Valve and their impact on therapeutic choices

Abstract Background: Isolated cleft mitral valve (ICMV) may occur alone or in association with other congenital heart lesions. The aim of this study was to describe the profile of cardiac lesions associated with ICMV and their potential impact on therapeutic management. Methods: We conducted a descriptive study with data retrieved from the Congenital Heart Disease (CHD) single-center registry of our institution, including patients with ICMV registered between December 2008 and November 2014. Results: Among 2177 patients retrieved from the CHD registry, 22 (1%) had ICMV. Median age at diagnosis was 5 years (6 days to 36 years). Nine patients (40.9%) had Down syndrome. Seventeen patients (77.3%) had associated lesions, including 11 (64.7%) with accessory chordae in the left ventricular outflow tract (LVOT) with no obstruction, 15 (88.2%) had ventricular septal defect (VSD), three had secundum atrial septal defect, and four had patent ductus arteriosus. Thirteen patients (59.1%) required surgical repair. The decision to proceed with surgery was mainly based on the severity of the associated lesion in eight patients (61.5%) and on the severity of the mitral regurgitation in four patients (30.8%). In one patient, surgery was decided based on the severity of both the associated lesion and mitral regurgitation. Conclusion: Our study shows that ICMV is rare and strongly associated with Down syndrome. The most common associated cardiac abnormalities were VSD and accessory chordae in the LVOT. We conclude that cardiac lesions associated with ICMV are of major interest, since in this study patients with cardiac lesions were diagnosed earlier. The decision to operate on these patients must take into account the severity of both mitral regurgitation and associated cardiac lesions.

Mortality from Circulatory System Diseases and Malformations in Children in the State of Rio de Janeiro

Abstract Background: The epidemiological profile of mortality in a population is important for the institution of measures to improve health care and reduce mortality Objective: To estimate mortality rates and the proportional mortality from cardiovascular diseases and malformations of the circulatory system in children and adolescents. Methods: This is a descriptive study of mortality from cardiovascular diseases, malformations of the circulatory system, from all causes, ill-defined causes and external causes in children and adolescents in the state of Rio de Janeiro from 1996 to 2012. Populations were obtained from the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística - IBGE) and deaths obtained from the Department of Informatics of the Unified Health System (DATASUS)/Ministry of Health. Results: There were 115,728 deaths from all causes, 69,757 in males. The annual mortality from cardiovascular diseases was 2.7/100,000 in men and 2.6/100,000 in women. The annual mortality from malformations of the circulatory system was 7.5/100,000 in men and 6.6/100,000 in women. Among the specific causes of circulatory diseases, cardiomyopathies had the highest rates of annual proportional mortality, and from malformations of the circulatory system, it occurred due to unspecified malformations of the circulatory system, at all ages and in both genders. Conclusion: Mortality from malformations of the circulatory system was most striking in the first years of life, while cardiovascular diseases were more relevant in adolescents. Low access to prenatal diagnosis or at birth probably prevented the proper treatment of malformations of the circulatory system.

Bestimmung der Therapiedosis von kolorektalen Mikrometastasen und der Toleranzdosis des Leberparenchyms nach computertomographisch gesteuerter monofraktionärer Hochdosis-Brachytherapie mit 192Iridium

Magdeburg, Univ., Medizin. Fakultät, Diss., 2009

Funktionelle Charakterisierung von mtch2 im Zebrafischmodell

Die steigende Zahl von Erkrankungen in Folge von Adipositas ist ein weltweites Gesundheitsproblem unserer Zeit. Genomweite Assoziationsstudien konnten single-nucleotide polymorphisms identifizieren, die in Zusammenhang mit Adipositas stehen könnten, darunter auch MTCH2. Weiterführende Untersuchungen konnten zeigen, dass MTCH2 eine regulatorische Rolle bei der Adipogenese einnimmt. Da mtch2 auch im Zebrafisch in verschiedenen Geweben und Organen wie Leber, Darm und Fettgewebe exprimiert wird, liegt die Vermutung nahe, dass es in diesen Organen und Geweben eine Funktion aufweist. Diese Funktion sollte über einen Morpholino-induzierten Knockdown des Gens und die Analyse des Phänotyps der Morpholino-injizierten Fische näher analysiert werden. Der Knockdown von mtch2 im Zebrafisch wurde mit Hilfe zweier Splice-Morpholinos induziert und über quantitative Real Time PCR identifiziert. Die Auswirkungen des Knockdowns auf die Entwicklung von Leber und Darm der Fische wurde über spezifische Marker mit der Methode der In situ Hybridisierung untersucht. Die Adipozytenbildung wurde durch Nilrotfärbung analysiert und über die Fütterung der Fische mit fluoreszierenden Beads mit dem Essverhalten in Zusammenhang gebracht. Bei beiden Morpholinos führte der Knockdown von mtch2 an Tag 4 der Entwicklung der Morpholino-injizierten Zebrafische zu Auffälligkeiten in der Ausbildung von Leber und Darm der Fische, die aber nicht mit einer generellen Störung der Entwicklung der Tiere einherging. An Tag 8 der Entwicklung der Zebrafische zeigte sich hingegen, dass die Tiere im Gegensatz zu den Kontroll-injizierten Fischen insgesamt kleiner beziehungsweise unterentwickelt waren, wobei dieser Umstand nicht mit ihrem Essverhalten in Zusammenhang gebracht werden konnte. Zudem konnte eine reduzierte Adipozytenbildung in den Morpholino-injizierten Zebrafischen festgestellt werden. (...)

Toxoplasmose congênita

We had the opportunity to study 6 cases of the congenital form of toxoplasmosis, found in a series of 1200 necropsies of fetuses and newborn babies, realized at 3 different hospitals in Rio de Janeiro, Brazil. Among the 6 cases, 4 were premature babies liveborn at the 6th-8th gestational month and 2 were stillborn (1 premature and 1 at term). In all those cases, the diagnosis was based in the detection of the parasite in tissues and in one case it was even isolated the Toxoplasma from the necrotic material found in the cranial cavity. This strain of Toxoplasma, pathogenic to pigeons, to guinea pigs and to mice, is preserved by successive transfers in mice. Some facts observed in those cases present an interest not only strictly anatomic but also have certain value for the better acknowlegment of the disease. First, we want to call the attention to the presence of a sudden high fever, during or just before pregnancy in the 4 cases in which the maternal anamnesis was perfectly studied; this fever that was preceded by a normal beginning of pregnancy, had relatively rapid remission, but in 2 cases was immediately followed by uterine bleeding and premature delivery, although the puerperium had been apparently normal. It is known that are normal the subsequent children of the mothers that delivered a baby with toxoplasmosis and that several women have normal babies before the toxoplasmotic one. We believe that the fever observed in our cases could be indicative of the beginning of maternal infection and those are the reasons why we emphasize the need of careful anamnesis, specially in the cases actually diagnosed as inapparent infection. Another fact to notice is that in 5 of our cases the event premature delivery happened always between the 6th and the 8th months of pregnancy, and the only term fetus was delivered in advanced stage of maceration. The above mentioned facts could agree with the opinion of FRENKEL (1949), when he declared that "primary infection of the pregnant mother appears more likely to be the commoner mode of fetal toxoplasmic infection", but they would disagree with WEINMAN (1952) who believes that the transmission of Toxoplasma to the fetus is more frequent through a pregnant woman with chronic disease and who says "that infection contracted during pregnancy may and probably does happen from time to time"...Still in connection with the transmission of toxoplasmosis, we want to note the verification of inflammatory lesions in the placental villi and in the umbilical cord in 3 of the 4 cases in which such organs were examined at the microscope. In the case n. 1, we found several pseudocysts of Toxoplasma in the placenta, and the fibroblasts of Wharton's jelly were particularly rich in isolated forms and in colonies of Toxoplasma; the easy multiplication of the parasite in that tissue calls the attention and even suggests its utilisation for Toxoplasma's cultivation. The confirmation of Toxoplasma in human placenta was made only recently by CRISTEN et al. (1951) and by NEGHME et al. (1952), in Chile; it is not frequent in the literature, what gives some value to our present verification. Another observation was that provided by the case n. 6. This baby, a premature one of the 6th month, was 14 days old and-died with signs of respiratory disease, the causa mortis have been pneumonia. At the necropsy, we found no gross change that suggested toxoplasmosis, except the presence of some small necrotic focuses in the cerebral nervous substance around the ventricles. As a matter of fact, there was no enlargement of spleen or liver and neither leptomeningitis nor hydrocephalus. Such focuses were attributed to possible anoxia and in fact they are extremely similar to anoxial softenings, even when they are examined at the microscope; its structure composed of a central necrotic zone, surrounded by proliferated neuroglia and by a variable deposit of calcium salts, closely simulated the anoxial softenings, when the microscopical examination is based in the common histological preparations (hematoxilin-eosin, etc.). But when we examine preparations by the Giemsa or by the periodic acid-Schiff methods, we will note the presence of Toxoplasma, with its typical aspect or a little changed by degeneration. When we describe this observation, we wish to evidence the need of the search of Toxoplasma and closed parasites, in the cases of supposed pure anoxial softenings of nervous substance, in children. The frequency with which the congenital toxoplasmosis was anatomically verified should be emphasized, although the disease had not been clinically suspected, and it should be borne in mind that the second case of toxoplasmosis reported in the world was observed in Brazil by MAGARINOS TORRES; this case was the first to be described of the generalized congenital form of the infection, i. e. with myocardial lesions and parasites in skeletal muscles and skin.

Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1.

The voltage-gated cardiac potassium channel hERG1 (human ether-à-gogo-related gene 1) plays a key role in the repolarization phase of the cardiac action potential (AP). Mutations in its gene, KCNH2, can lead to defects in the biosynthesis and maturation of the channel, resulting in congenital long QT syndrome (LQTS). To identify the molecular mechanisms regulating the density of hERG1 channels at the plasma membrane, we investigated channel ubiquitylation by ubiquitin ligase Nedd4-2, a post-translational regulatory mechanism previously linked to other ion channels. We found that whole-cell hERG1 currents recorded in HEK293 cells were decreased upon neural precursor cell expressed developmentally down-regulated 4-2 (Nedd4-2) co-expression. The amount of hERG1 channels in total HEK293 lysates and at the cell surface, as assessed by Western blot and biotinylation assays, respectively, were concomitantly decreased. Nedd4-2 and hERG1 interact via a PY motif located in the C-terminus of hERG1. Finally, we determined that Nedd4-2 mediates ubiquitylation of hERG1 and that deletion of this motif affects Nedd4-2-dependent regulation. These results suggest that ubiquitylation of the hERG1 protein by Nedd4-2, and its subsequent down-regulation, could represent an important mechanism for modulation of the duration of the human cardiac action potential.

12

Primary ciliary dyskinesia (PCD) is an autosomal recessive disease with an incidence estimated between 1:2,000 and 1:40,000. Ciliated epithelia line the airways, nasal and sinus cavities, Eustachian tube and fallopian tubes. Congenital abnormalities of ciliary structure and function impair mucociliary clearance. As a consequence, patients present with chronic sinopulmonary infections, recurrent glue ear and female subfertility. Similarities in the ultrastructure of respiratory cilia, nodal cilia and sperm result in patients with PCD also presenting with male infertility, abnormalities of left-right asymmetry (most commonly situs inversus totalis) and congenital heart disease. Early diagnosis is essential to ensure specialist management of the respiratory and otological complications of PCD. Diagnostic tests focus on analysis of ciliary function and electron microscopy structure. Analysis is technically difficult and labour intensive. It requires expertise for interpretation, restricting diagnosis to specialist centres. Management is currently based on the consensus of experts, and there is a pressing need for randomised clinical trials to inform treatment.

Optimisation du transfert de gènes dans la rétine par des vecteurs lentiviraux lors de maladies dégénératives de la rétine

Certaines dégénérescences rétiniennes sont engendrées par des mutations¦génétiques et conduisent à la perte des cellules photosensibles, les¦photorécepteurs (cônes et/ou bâtonnets), et donc à la cécité (Roy et al., 2010).¦La prévalence est de 1/3000 chez les Caucasiens. Les Rétinites Pigmentaires¦(RP) en composent la majorité des cas, suivent l'Amaurose congénitale de¦Leber et la maladie de Stargardt. Il n'y a pas une mutation type associés à une¦maladie mais diverses mutations peuvent aboutir à une dégénérescence de la¦rétine. Tout comme le reste du système nerveux central, la rétine lésée n'a pas¦les capacités de se régénérer. Un objectif du traitement est de ralentir la¦dégénérescence de la rétine dans le but de la stabiliser. La thérapie génique¦constitue actuellement la seule approche thérapeutique à même de traiter les¦dégénérescences rétiniennes d'origine génétique. Elle consiste à utiliser un virus¦modifié, qui n'a plus les capacités de se reproduire, appelé vecteur pour cibler¦certaines cellules afin d'ajouter un gène sain ou d'inhiber un gène malade. Les¦virus associés à l'adénovirus (AAV) et les Lentivirus (LV) sont les 2 principaux¦types de virus utilisés en thérapie génique en ophtalmologie. D'autres vecteurs¦existent, comme les adénovirus et le virus de l'anémie infectieuse équine. Des¦études de thérapie génique effectuées chez l'homme avec le vecteur AAV ont¦démontré une sensible amélioration des fonctions visuelles (acuité visuelle,¦champ visuel, pupillométrie et le déplacement dans un environnement avec une¦lumière tamisée) chez des patients atteints d'Amaurose congénitale de Leber¦(Maguire et al., Ali et al., Hauswirth et al., Bennett et al.). Le vecteur utilisé au¦cours de ce travail est un LV, qui a pour avantage de pouvoir transporter de¦grands gènes. Lorsque ce vecteur est pseudotypé avec une enveloppe VSVG, il¦transduit (transférer un gène qui sera fonctionnel dans la cellule cible) bien¦l'épithélium pigmentaire rétinien (nécessaire à la survie et à la fonction des¦photorécepteurs). Afin de changer le tropisme du vecteur, celui testé dans cette¦étude contient une enveloppe de type Mokola qui cible efficacement les cellules¦gliales du cerveau et donc probablement aussi les cellules de Müller de la rétine.¦Le but à court terme est de transformer génétiquement ces cellules pour leur¦faire sécréter des molécules favorisant la survie des photorécepteurs. Pour¦révéler la cellule ciblée par le vecteur, le gène qui sera exprimé dans les cellules¦transduites code pour la protéine fluorescente verte 2 (GFPII) et n'a pas de¦fonction thérapeutique. Après avoir produit le virus, deux types de souris ont été¦injectées : des souris dépourvues du gène de la rhodopsine appelées Rho -/- et¦des souris sauvages appelées C57BL6. Les souris Rho -/- ont été choisies en¦tant que modèle de dégénérescence rétinienne et les souris C57BL6 en tant que¦comparatif. Les souris Rho -/- et C57BL56 ont été injectées entre le 2ème et le¦3ème mois de vie et sacrifiées 7 jours après. Des coupes histologiques de la rétine¦ont permis de mesurer et comparer pour chaque oeil, les distances de¦transduction du RPE et de la neurorétine (= toute la rétine sauf le RPE). La¦distance sur laquelle le RPE est transduit détermine la taille de la bulle¦d'injection alors que la distance sur laquelle la neurorétine est transduite¦détermine la capacité du vecteur à diffuser dans la rétine. Les résultats montrent¦une expression plus importante de la GFPII dans le RPE que dans la neurorétine¦chez les souris Rho -/- et C57BL6. Les principales cellules transduites au¦niveau de la neurorétine sont, comme attendu, les cellules de Müller. Lorsque¦l'on compare les proportions de neurorétine et de RPE transduites, on constate¦qu'il y a globalement eu une meilleure transduction chez les souris Rho -/-¦que chez les souris C57BL6. Cela signifie que le vecteur est plus efficace pour¦transduire une rétine dégénérée qu'une rétine saine. Pour déterminer quels types¦de cellules exprimaient la GFPII, des anticorps spécifiques de certains types de¦cellules ont été utilisés. Ces résultats sont similaires à ceux d'autres études¦effectuées précédemment, dont celle de Calame et al. en 2011, et tendent à¦prouver que le vecteur lentiviral avec l'enveloppe Mokola et le promoteur EFs¦est idéal pour transduire avec un gène thérapeutique des cellules de Müller dans¦des rétines en dégénérescence.

Transcatheter stent-valve implantation in a stenotic pulmonary conduit via a sub-xyphoidian access

Patients who develop a severe stenosis in biological pulmonary conduits previously implanted for pulmonary outflow trunk reconstructions are treated either by surgical re-replacement, or by transcatheter stent-valve implantation through a femoral vein access. A catheter-based sub-xyphoidian access through the right ventricle for stent-valve positioning in a pulmonary conduit has rarely been proposed. We describe the case of a 20-year-old man who underwent a pulmonary trunk reconstruction for a congenital pulmonary valve dysplasia and a few years later developed a stenosis in the pulmonary conduit. He was successfully treated with a 23 mm Edwards Sapien stent-valve implantation in pulmonary position, through an unusual right ventricular, sub-xyphoidian access and without contrast medium injections and pleura opening.

Clinical and genetic investigation of a large Tunisian family with complete achromatopsia: identification of a new nonsense mutation in GNAT2 gene.

Complete achromatopsia is a rare autosomal recessive disease associated with CNGA3, CNGB3, GNAT2 and PDE6C mutations. This retinal disorder is characterized by complete loss of color discrimination due to the absence or alteration of the cones function. The purpose of the present study was the clinical and the genetic characterization of achromatopsia in a large consanguineous Tunisian family. Ophthalmic evaluation included a full clinical examination, color vision testing and electroretinography. Linkage analysis using microsatellite markers flanking CNGA3, CNGB3, GNAT2 and PDE6C genes was performed. Mutations were screened by direct sequencing. A total of 12 individuals were diagnosed with congenital complete achromatopsia. They are members of six nuclear consanguineous families belonging to the same large consanguineous family. Linkage analysis revealed linkage to GNAT2. Mutational screening of GNAT2 revealed three intronic variations c.119-69G>C, c.161+66A>T and c.875-31G>C that co-segregated with a novel mutation p.R313X. An identical GNAT2 haplotype segregating with this mutation was identified, indicating a founder mutation. All patients were homozygous for the p.R313X mutation. This is the first report of the clinical and genetic investigation of complete achromatopsia in North Africa and the largest family with recessive achromatopsia involving GNAT2; thus, providing a unique opportunity for genotype-phenotype correlation for this extremely rare condition.